NTRA - Rasio utang marang kapitalisasi buku Natera Inc

Logo grafis Natera (NTRA)

Natera, Inc. (NTRA) is a leading player in genetics whose success is based on unique datasets and non-invasive screening. The issuer is expanding its service profile from reproduction to oncology monitoring, thereby minimizing risks. A focus on the US domestic market eliminates external political pressure. The debt-to-market cap ratio on GURU.Markets yields the current status of 0.13, demonstrating the business's financial stability.

Natera Medical (NTRA) - Utang-utang marang nilai buku saka 04.07.2022 nganti 28.10.2026

Rincian metrik lan analitis perusahaan Natera Inc (NTRA)

- rega lan prakiraan konsensus rega:
Bagan rega Natera, Inc.|NTRA - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Nilai pasar Natera Medical|NTRA - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Natera|NTRA - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku natera.com|NTRA - Total Aset Bisnis
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Natera, Inc.|NTRA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Natera Corp|NTRA - Gunggung utang perusahaan|Utang marang nilai buku Natera Medical|NTRA - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Natera
Analisis kabeh metrik perusahaan:NTRA Natera, Inc.
Sampel barang Natera Inc

This metric reflects leverage dynamics, measuring the proportion of borrowed funds relative to equity to assess the business's financial stability. This ratio of debt obligations to balance sheet capital demonstrates how aggressively Natera, Inc. (NTRA) is financing its expansion into the high-margin oncology testing segment, allowing investors to promptly identify a critical increase in debt load amid the company's rapid scaling.

Pesaing Natera, Inc.

Humacyte, Inc. (HUMA) - Rasio utang marang kapitalisasi buku|seraprognostics.com - Rasio utang-utang marang kapitalisasi buku